International Biophysics, VGM ink deal

Thursday, November 13, 2014

AUSTIN, Texas – International Biophysics Corporation has partnered with The VGM Group to become a preferred vendor for its AffloVest, it was announced yesterday. The AffloVest provides daily portable oscillation treatment for respiratory diseases, such as Cystic Fibrosis, Bronchiectasis, ALS, MS, MD and COPD. “We’re thrilled to connect our members to this innovative technology that will improve their patients’ quality of life,” said Van Miller, CEO and founder of VGM, in a release.